Ebola Virus

Novel Vaccine Protects Monkeys from Deadly Infection

Published in Gene Therapy Weekly, December 21st, 2000

Few viruses are more feared than Ebola virus, the deadly microbe that periodically attacks African villages and kills up to 90% of those it infects. Although other viral diseases claim more lives each year, the ruthless efficiency and nightmarish symptoms of Ebola virus make a vaccine against this killer an important goal of scientists.

Now, as described in the November 30, 2000, issue of Nature, a team of researchers led by scientists from the U.S. National Institutes of Health (NIH) has developed a novel vaccine that prevents Ebola virus infection in monkeys. All four vaccinated monkeys were completely protected from a lethal dose of the virus. This study...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2000-12-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry